NewEdge Advisors LLC lifted its stake in abrdn Healthcare Investors (NYSE:HQH – Free Report) by 32.7% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 151,738 shares of the financial services provider’s stock after acquiring an additional 37,393 shares during the period. NewEdge Advisors LLC owned 0.27% of abrdn Healthcare Investors worth $2,699,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Bollard Group LLC bought a new position in shares of abrdn Healthcare Investors in the first quarter valued at approximately $25,000. Geneos Wealth Management Inc. boosted its holdings in shares of abrdn Healthcare Investors by 9,232.3% during the 2nd quarter. Geneos Wealth Management Inc. now owns 2,893 shares of the financial services provider’s stock worth $45,000 after buying an additional 2,862 shares during the period. Advisory Services Network LLC acquired a new position in abrdn Healthcare Investors in the 3rd quarter valued at $97,000. Global Retirement Partners LLC bought a new position in abrdn Healthcare Investors in the 4th quarter worth $106,000. Finally, PNC Financial Services Group Inc. bought a new position in abrdn Healthcare Investors in the 4th quarter worth $107,000. 32.60% of the stock is currently owned by institutional investors and hedge funds.
abrdn Healthcare Investors Price Performance
abrdn Healthcare Investors stock opened at $23.61 on Friday. abrdn Healthcare Investors has a fifty-two week low of $16.01 and a fifty-two week high of $23.69. The firm has a fifty day moving average price of $21.28 and a two-hundred day moving average price of $19.91.
abrdn Healthcare Investors Dividend Announcement
About abrdn Healthcare Investors
abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.
The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.
Further Reading
- Five stocks we like better than abrdn Healthcare Investors
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
